Optical News

DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the fourth quarter and fiscal year ended January 3, 2026, and is providing its outlook for fiscal 2026. Alex Wilkes, National Vision’s CEO, said, “2025 was a remarkable year for National Vision – one in which we embarked on a bold reinvention of our company and executed our plan with discipline and precision, achieving results that surpassed ou...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued a Shareholder Letter on Tuesday, March 3 after the market close. STAAR’s results release can be found here: https://investors.staar.com/news-and-events/press-releases. Fellow Shareholders, This past month marked an important transition for our company as we stepped into the roles of Interi...

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal year ended January 2, 2026. STAAR’s Interim co-CEOs will be issuing a Letter to Shareholders after this earnings release, which can be found here: https://investors.staar.com/news-and-events/press-releases. Fourth Quarter 2025 Financial Overview...

HEBRON, Ky.--(BUSINESS WIRE)--ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, today announced a strategic partnership with Medical Eyeglass Center (MEC), a nationally recognized, full-service optical dispensary management organization. The collaboration establishes ZEISS as the exclusive laboratory and service provider within MEC’s optical dispensary management organization. MEC will serve as the exclusive optical dispensary management...

WINNETKA, Ill.--(BUSINESS WIRE)--Hadley is working with UnitedHealthcare Vision to help ensure that more people experiencing vision loss have access to emotional support resources alongside their traditional eye care. As part of the collaboration, UnitedHealthcare Vision will help broaden awareness of Adjusting & Coping Together, Hadley’s free new video series focused on the emotional and psychological realities of vision loss. Vision loss affects more than 30 million people in the United S...

ST. LOUIS--(BUSINESS WIRE)--EyeCare Partners 2025 Quality & Outcomes Report offers a comprehensive look at clinical performance across a national, physician-led eye care network....

NASHVILLE, Tenn.--(BUSINESS WIRE)--Sanaregen Vision Therapeutics, a clinical-stage regenerative medicine company, today announced clearance by the U.S. Food and Drug Administration to conduct a Phase I/II clinical trial for SVT-001, its investigational cell therapy. The trial will assess safety and effectiveness of SVT-001 to improve retinal function and restore vision in individuals with Familial Drusen, an inherited form of macular degeneration. There are currently no approved disease-modifyi...

NEUCHÂTEL, Switzerland--(BUSINESS WIRE)--Unlike traditional EDOF lenses, Lucidis® delivers full-range visual performance comparable to a premium trifocal IOL without disturbances....

GENEVA--(BUSINESS WIRE)--Alcon Surpasses 175 Million IOLs Implanted Globally...

SAN DIEGO--(BUSINESS WIRE)--RevolutionEHR, the market-leading optometry-first operating platform, today announced the launch of RevPay, its fully embedded payments solution designed to help practices get paid effortlessly while recovering more of the revenue they earn. RevPay connects payments directly to RevolutionEHR’s AI-native platform, integrating checkout, patient records, engagement, and reporting into one intelligent workflow. By embedding payments into the platform’s intelligence engin...